Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Cloning of a novel signaling molecule, AMSH-2, that potentiates transforming growth factor beta signaling.

Ibarrola N, Kratchmarova I, Nakajima D, Schiemann WP, Moustakas A, Pandey A, Mann M.

BMC Cell Biol. 2004 Jan 19;5:2.

2.

Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.

Itoh F, Asao H, Sugamura K, Heldin CH, ten Dijke P, Itoh S.

EMBO J. 2001 Aug 1;20(15):4132-42.

4.

Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.

Mazerbourg S, Klein C, Roh J, Kaivo-Oja N, Mottershead DG, Korchynskyi O, Ritvos O, Hsueh AJ.

Mol Endocrinol. 2004 Mar;18(3):653-65. Epub 2003 Dec 18.

PMID:
14684852
5.

TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.

Felici A, Wurthner JU, Parks WT, Giam LR, Reiss M, Karpova TS, McNally JG, Roberts AB.

EMBO J. 2003 Sep 1;22(17):4465-77.

6.

The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.

Hanyu A, Ishidou Y, Ebisawa T, Shimanuki T, Imamura T, Miyazono K.

J Cell Biol. 2001 Dec 10;155(6):1017-27. Epub 2001 Dec 10.

7.

An RNF11: Smurf2 complex mediates ubiquitination of the AMSH protein.

Li H, Seth A.

Oncogene. 2004 Mar 11;23(10):1801-8.

PMID:
14755250
8.
9.

Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling.

Mochizuki T, Miyazaki H, Hara T, Furuya T, Imamura T, Watabe T, Miyazono K.

J Biol Chem. 2004 Jul 23;279(30):31568-74. Epub 2004 May 17.

10.
11.

Characterization of a unique motif in LIM mineralization protein-1 that interacts with jun activation-domain-binding protein 1.

Sangadala S, Yoshioka K, Enyo Y, Liu Y, Titus L, Boden SD.

Mol Cell Biochem. 2014 Jan;385(1-2):145-57.

12.

CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.

Xin H, Xu X, Li L, Ning H, Rong Y, Shang Y, Wang Y, Fu XY, Chang Z.

J Biol Chem. 2005 May 27;280(21):20842-50. Epub 2005 Mar 21.

13.
14.

Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.

Ferrigno O, Lallemand F, Verrecchia F, L'Hoste S, Camonis J, Atfi A, Mauviel A.

Oncogene. 2002 Jul 25;21(32):4879-84.

15.

Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.

Bondestam J, Kaivo-oja N, Kallio J, Groome N, Hydén-Granskog C, Fujii M, Moustakas A, Jalanko A, ten Dijke P, Ritvos O.

Mol Cell Endocrinol. 2002 Sep 30;195(1-2):79-88.

PMID:
12354674
16.

Casein kinase Iepsilon plays a functional role in the transforming growth factor-beta signaling pathway.

Waddell DS, Liberati NT, Guo X, Frederick JP, Wang XF.

J Biol Chem. 2004 Jul 9;279(28):29236-46. Epub 2004 May 7.

17.

Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.

Kurisaki K, Kurisaki A, Valcourt U, Terentiev AA, Pardali K, Ten Dijke P, Heldin CH, Ericsson J, Moustakas A.

Mol Cell Biol. 2003 Jul;23(13):4494-510.

19.

Possible involvement of a novel STAM-associated molecule "AMSH" in intracellular signal transduction mediated by cytokines.

Tanaka N, Kaneko K, Asao H, Kasai H, Endo Y, Fujita T, Takeshita T, Sugamura K.

J Biol Chem. 1999 Jul 2;274(27):19129-35.

20.

TGF-beta signaling in colon cancer cells.

Li F, Cao Y, Townsend CM Jr, Ko TC.

World J Surg. 2005 Mar;29(3):306-11.

PMID:
15711891

Supplemental Content

Support Center